Skip to main content
Department of Health Department of Health An Roinn Sláinte Männystrie O Pouste

Main navigation

  • Home
  • Topics
  • Publications
  • Consultations
  • Contact

Translation help

Translate this page

Select a language

  • Arabic — عربي
  • Chinese (Simplified) — 中文简体
  • Chinese (Traditional) — 中文繁體
  • Dutch — Nederlands
  • Filipino — Filipino
  • French — Français
  • German — Deutsch
  • Hungarian — Magyar
  • Irish — Gaeilge
  • Italian — Italiano
  • Latvian — Latviešu
  • Lithuanian — Lietuvių kalba
  • Polish — Polski
  • Portuguese — Português
  • Romanian — Română
  • Russian — Русский
  • Slovak — Slovenčina
  • Spanish — Español
  • Ukrainian — Українська

    • Drug Alerts - 2025

    Date published: 10 January 2025

    Last updated: 9 May 2025

    Drug alerts issued by DoH during 2025

    Documents

    • PHC-01-2025 - Class 4 Medicines Notification - Bristol Laboratories Limited, Rabeprazole sodium 10mg gastro-resistant tabletsAdobe PDF (127.22 KB)
    • PHC-02-2025 - Medicines Recall - Class 4 - Jubilant Pharmaceuticals NV - Irbesartan 150 mg and 300 mg film-coated ~ PL 19156 0089Adobe PDF (340.36 KB)
    • PHC-03-2025 - Strong Dry Tickly Cough 200ml, Almus Dry Cough Relief, Bells Dual Action Dry CoughAdobe PDF (101.04 KB)
    • PHC-03-2025 - UPDATE - Class 2 Recall - Bell, Sons & Co (Druggists) Ltd T A Bells Healthcare, Tesco Health Dry Cough Relief 200ml, Asda Strong Dry Tickly Cough 200ml, Almus DAdobe PDF (204.48 KB)
    • PHC-04-2025 - Class 2 Recall - Bristol Laboratories Limited, Amlodipine Bristol Lab 2.5 mg Tablets - PL 17907 0435Adobe PDF (166.4 KB)
    • PHC-05-2025 - Class 2 Medicines Recall - CNX Therapeutics Limited, Nitrofurantoin CNX Therapeutics -Release capsules PL 19635 0006Adobe PDF (180.28 KB)
    • PHC-06-2025 - Medicines Notification - Class 4 Caution in Use - Teva UK Limited, ~ resistant Hard Capsules 15mg PL 10622 0308Adobe PDF (146.87 KB)
    • PHC-07-2025 - Class 3 Medicines Recall - Uni Health Distribution Savio - release TabletsAdobe PDF (251.34 KB)
    • PHC-08-2025 - Class 3 Medicines Recall Azacitidine 100 mg vial and 150 mg vial Powder for Suspension for Injection, EL(25)A 08Adobe PDF (180 KB)
    • PHC-09-2025 - Class 2 - Sun Pharmaceutical Industries Europe B.V. Pemetrexed SUN 10 mg ml solution for infusion (Infusion bag)Adobe PDF (142.75 KB)
    • PHC-10-2025 - Class 2 Medicines Recall - Aspar Pharmaceuticals Limited - Boots Paracetamol 500 mg tablets (16s)(2)Adobe PDF (486.29 KB)
    • PHC-11-2025 - Class 4 Medicines Notification - Jubilant Pharmaceuticals NV - Azithromycin 250 mg Capsules Licence PL 19156 0138Adobe PDF (188.8 KB)
    • PHC-12-2025 - Class 4 Notification Cross Healthcare Limited Sirdupla 25 microgram 250 microgram per metered dose pressurised inhalation suspensionAdobe PDF (219.2 KB)
    • PHC-13-2025 - Class 2 Recall alert for 01 April 2025. Uni Health Distribution Ltd Utrogestan Vaginal 200 mg CapsulesAdobe PDF (122.3 KB)
    • PHC-14-2025 - Class 3 Recall - Rosemont Pharmaceuticals Ltd, Urospir 50mg-5ml Oral Solution (Spironolactone)Adobe PDF (186.15 KB)
    • PHC-15-2025 - Class 4 Medicines Defect - RenaCare NephroMed GmbH, Renacet 475 mg, film-coated tablets, PL 36032 0001Adobe PDF (136.79 KB)
    • PHC-16-2025 - Class 2 Medicines Recall - Reig Jofre UK - Synalar GEL 30g and Synalar Gel 60gAdobe PDF (133.26 KB)
    • PHC-17-2025 - Class 2 Medicines Recall notification - EL(25)A/17 - Lercanidipine HCl 20mg TabletsAdobe PDF (204.48 KB)
    • PHC-18-2025 - Class 4 notification_ticagrelor_Parallel ImportAdobe PDF (124.03 KB)
    • PHC-19-2025 - Class 4 Medicines Defect Notification: Pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg Capsules, Jubilant Pharmaceuticals NV, EL(25)A/19Adobe PDF (176.59 KB)
    • PHC-20-25 - Class 4 medicines notification Chemidex Pharma LtdAdobe PDF (167.52 KB)
    • PHC-21-2025 - Class 4 Medicines Defect Information EL(25)A/20 - Chloramphenicol 1% w/w Eye OintmentAdobe PDF (127.13 KB)
    • PHC-22-2025 - Class 2 Medicines Recall - Becton Dickinson UK Ltd BD ChloraPrep Clear - 1mL Applicator PL 059200002Adobe PDF (137.27 KB)
    • PHC-23-25 - Class 2 Medicines Recall Mercaptopurine 50mg tablets EL(25)A/23Adobe PDF (123.37 KB)
    • PHC-24-2025 - Class 4 Medicines defect information Caution In Use EL(25)A/24Adobe PDF (209.59 KB)
    • PHC-25-2025 - Class 2 Medicines Recall Notification - Paracetamol 500mg Tablets EL(25)A/25Adobe PDF (124.5 KB)
    • PHC-26-2025 - Class 4 Medicines Defect Information Dulcolax Adult 5 mg Gastro-resistant Tablets EL(25)A/26Adobe PDF (157.02 KB)
    • PHC-27-2025 - Class 2 recall Inhixa 12,000IU (120mg)0.8mL solution for injection EL(25)A27Adobe PDF (289.06 KB)
    • PHC-28-2025 - Class 3 Medicines Recall - Immunocore Limited Kimmtrak 200 micrograms mL concentrate for solution for infusion - EL(25)A28Adobe PDF (152.21 KB)
    • PHC-29-2025 – Class 2 Medicines Recall Depo-Medrone 80mg in 2 ml suspension for injection EL(25)A/29Adobe PDF (332.45 KB)
    • PHC-30-2025 – Class 3 Medicines Recall Glenmark Pharmaceuticals Europe Ltd Omeprazole 20 mg/15 ml Oral Solution EL(25)A/30Adobe PDF (125.15 KB)
    • PHC-31-2025 - Class 3 Medicines Recall Wockhardt UK Ltd Tamoxifen 20mg Film-Coated Tablets EL(25)A/31Adobe PDF (123.5 KB)
    • PHC-32-2025 - Class 4 Medicines Defect Notification Erythromycine Stearate BP 250mg Tablets EL(25)A/32Adobe PDF (149.27 KB)
    • PHC-33-2025 - Class 4 Medicines Defect Notification Simvastatin 10mg Tablet EL(25)A/33Adobe PDF (124.15 KB)
    • PHC-34-2025 - Class 2 Medicines Recall Zaditen 0.25 mg/ml, eye drops, solution EL(25)A/34Adobe PDF (135.22 KB)
    • EL(25)A/35 - CLASS 2 MEDICINES RECALL, Adobe PDF (301.3 KB)
    • Class 2 recall ChloraPrep 1ml Clear Sterile SolutionAdobe PDF (121.32 KB)
    • PHC-37-2025 - Class 4 Medicines Defect Notification - Olmesartan Medoxomil 10mg, 20mg film-coated tablets EL(25)A/37Adobe PDF (214.8 KB)
    • PHC-38-2025 - Class 2 Medicines Recall - Fucidin 250 mg Tablets EL(25)A/38Adobe PDF (121.46 KB)
    • Class 4_Zydus_topiramate_PILAdobe PDF (121.88 KB)
    • Class 4 - EL25A40 - Levetiracetam AccordAdobe PDF (156.69 KB)
    • PHC-41-2025 - Class 4 Medicines Defect Information - Fexofenadine Hydrochloride 120mg film-coated tablets EL(25)A/41Adobe PDF (136.35 KB)
    • PHC-42-2025 - Class 4 Medicines Defect Information-Various EL(25)A42Adobe PDF (385.99 KB)
    • PHC-43-2025 - Class 4 Medicines Defect Information - Gemcitabine 2g/52.6ml concentrate for solution for infusion EL(25)A/43Adobe PDF (163.34 KB)
    • PHC-44-2025 - Class 4 Medicines Defect Notification: Relonchem Ltd, Various Products, EL(25)A/44Adobe PDF (145.29 KB)
    • PHC-45-2025 - Class 3 Medicines Recall: Accord Healthcare Ltd, Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution, EL(25)A/45Adobe PDF (146.67 KB)
    • EL(25)A46 Hartmanns C2 defectAdobe PDF (146.41 KB)
    • PHC-47-2025 - Class 3 Medicines Recall Emylif 50mg orodispersible film - EL(25)A47Adobe PDF (108.33 KB)
    • PHC-48-2025 - Class 3 Medicines Recall Notification - Atorvastatin 20 mg and 80 mg Film-coated Tablets- EL(25)A/48Microsoft Word (95.84 KB)
    Share this page Share on Facebook (external link opens in a new window / tab) Share on X (external link opens in a new window / tab) Share by email (external link opens in a new window / tab)

    Department footer links

    • Crown copyright
    • Terms and Conditions
    • Privacy
    • Cookies
    • Accessibility
    • The Northern Ireland Executive
    • The Executive Office
    • Department of Agriculture, Environment and Rural Affairs
    • Department for Communities
    • Department for Education
    • Department for the Economy
    • Department of Finance
    • Department for Infrastructure
    • Department for Health
    • Department of Justice
    • nidirect.gov.uk — the official government website for Northern Ireland citizens